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Resumo
Introdução: A associação entre bem-estar psicológico e saúde 
física e mental tem sido demonstrada na literatura. Bem-
estar psicológico é um conceito multifacetado. O World Health 
Organization-5 Well-Being Index (WHO-5) é um instrumento 
composto por 5 itens utilizado para avaliar depressão. No 
entanto, a validade do WHO-5 não foi investigada em contextos 
psiquiátricos ou psicológicos iranianos.
Objetivo: Investigar a validade da versão persa do WHO-5 em 
uma amostra de pacientes psiquiátricos ambulatoriais iranianos.
Métodos: Um estudo transversal foi conduzido com uma amostra de 
conveniência composta por 116 pacientes psiquiátricos ambulatoriais 
iranianos voluntários selecionados nas clínicas psiquiátrica e 
psicológica da School of Behavioral Sciences and Mental Health, 
Tehran Institute of Psychiatry, Iran University of Medical Sciences. Os 
pacientes completaram o WHO-5, o Patient Health Questionnaire-9 
(PHQ-9), o Patient Health Questionnaire-15 (PHQ-15) e a versão 
abreviada do Beck Depression Inventory-13 (BDI-13). 
Resultados: O escore médio obtido no WHO-5 foi de 8,95 (desvio 
padrão = 5,49). O alfa de Cronbach para o WHO-5 foi 0,91. O 
WHO-5 se correlacionaram negativamente com o PHQ-9 (-0,358), 
o PHQ-15 (-0,328) e o BDI-13 (-0,475), indicando validade 
adequada. A análise fatorial dos itens do WHO-5 identificaram um 
único fator, a saber, bem-estar psicológico. 
Conclusão: O WHO-5 tem uma estrutura dimensional única e 
parâmetros psicométricos aceitáveis. Os resultados deste estudo 
sugerem que o WHO-5 pode ser usado em contextos clínicos no 
Irã.
Descritores: Bem-estar psicológico, validade, confiabilidade, 
estrutura fatorial, WHO-5, pacientes psiquiátricos ambulatoriais, Irã.
Abstract
Introduction: The association between psychological well-being 
and physical and mental health has been shown in the literature. 
Psychological well-being is a multifaceted concept. The World 
Health Organization-5 Well-Being Index (WHO-5) is a 5-item 
instrument used to screen for depression. However, the validity 
of the WHO-5 has not been investigated in Iranian psychiatric or 
psychological settings.
Objective: To investigate the validation of the Farsi version of the 
WHO-5 in a sample of Iranian psychiatric outpatients.
Methods: A cross-sectional study was conducted with a 
convenience sample of 116 Iranian volunteer psychiatric 
outpatients selected from the psychiatric and psychological clinics 
at the School of Behavioral Sciences and Mental Health – Tehran 
Institute of Psychiatry, Iran University of Medical Sciences. Patients 
completed the WHO-5, the Patient Health Questionnaire-9 (PHQ-
9), the Patient Health Questionnaire-15 (PHQ-15), and the short 
form of the Beck Depression Inventory-13 (BDI-13). 
Results: The mean score of the WHO-5 was 8.95 (standard 
deviation [SD] = 5.49). Cronbach’s α for the WHO-5 was 0.91. 
The WHO-5 negatively correlated with PHQ-9 (-0.358), PHQ-
15 (-0.328), and BDI-13 (-0.475), indicating good validity. 
Factor analysis of the WHO-5 items identified one factor labeled 
psychological well-being. 
Conclusions: The WHO-5 has a single dimensional structure and 
acceptable psychometric parameters. The results of this study 
suggest that WHO-5 can be used in a clinical context in Iran.
Keywords: Psychological well-being, validity, reliability, factorial 
structure, WHO-5, psychiatric outpatients, Iran.
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Introduction
Well-being is a multifaceted, dynamic, complicated 
construct. There are many different studies of key 
dimensions of well-being.1 Well-being has components 
of psychological well-being/subjective well-being and 
emotional well-being.2,3 
Psychological well-being and emotional well-being 
concepts were developed by researchers in the field of 
positive psychology, health psychology, organizational 
psychology and organizational behavior. Psychological well-
being assesses well-being and it correlates with physical 
health. It refers to how people evaluate their personal and 
social life (i.e., internal experience and their perception of 
life).4-7 Emotional well-being, in turn, is necessary to the 
individual’s health as a whole. It has been correlated with 
mental health issues8,9 and related to facets or Ryff’s six 
domains of psychological well-being.10,11 
The World Health Organization-5 Well-Being Index 
(WHO-5) can be used as a tool when screening for 
depressive symptoms, monitoring emotional well-being 
and psychological well-being,12-17 and also to assess the 
severity of suicide attempts.18,19 
The validity of the WHO-5 has not been so far 
investigated in Iranian psychiatric and psychological 
settings. We examined psychometric and screening 
parameters for psychological well-being of this index in 
a sample of Iranian psychiatric outpatients. 
Methods
A convenience sample of 116 Iranian volunteer 
psychiatric outpatients was selected from the psychiatric 
and psychological clinics at one site in Tehran, Iran, 
namely, the School of Behavioral Sciences and Mental 
Health – Tehran Institute of Psychiatry, affiliated with 
the Iran University of Medical Sciences. The patients 
were invited to voluntarily participate in the study after 
completing a psychiatric interview with one psychiatrist. 
Patients who agreed to participate provided written 
consent. The study protocol was approved by an 
institutional review board. 
The patients completed the Farsi versions of the 
WHO-5, the Patient Health Questionnaire-9 (PHQ-9), the 
Patient Health Questionnaire-15 (PHQ-15), and the short 
form of the Beck Depression Inventory-13 (BDI-13). 
World Health Organization-5 Well-Being Index 
(WHO-5)
The five items of the WHO-5 are associated with 
positive mood, vitality, and general interests; each of 
the items is rated on a 6-point Likert scale. Previous 
studies have reported acceptable psychometric 
parameters of the WHO-5 in different versions and 
in various clinical and non-clinical samples.15,20-27 The 
Farsi version of the WHO-5 was available at the WHO 
website in 2017.28
Patient Health Questionnaire-9 (PHQ-9)
The PHQ-9 is a tool designed for the assessment of 
depression. It contains nine items focusing on the past 
two weeks; each item is scored using a 4-point Likert 
scale ranging from 0 to 3. Previous studies have shown 
good psychometric characteristics for the PHQ-9.21,29-38 
Patient Health Questionnaire-15 (PHQ-15)
The PHQ-15 is a short, self-reported instrument 
used to screen for somatoform symptoms. It covers 
15 somatic symptoms and focuses on the past four 
weeks. Each symptom is scored from 0 to 2. Studies 
have indicated high internal consistency and acceptable 
validity for the PHQ-15.37 For example, the PHQ-15 
correlated with the Patient Health Questionnaire-2 
(PHQ-2) at 0.45.27 
Short form of the Beck Depression Inventory-13 
(BDI-13)
The BDI-13 is a screening instrument for depressive 
symptoms. Good psychometric properties have been 
reported, and three factors identified, for the BDI-13.39 
The BDI-13 correlated with the PHQ-2 at 0.69.27
Results
The mean age of the patients was 35.48 years 
(standard deviation [SD] = 12.20). Mean duration of 
psychiatric disorder was 5.61 years (SD=5.16). In the 
total sample, 81.8% were female; 48.1% were single, 
46.3% married, 4.6% divorced, and 0.9% widowed. 
The majority had 12 years of education (59.7%), and 
40.4% had a bachelor’s degree (BA) and higher degree. 
With regard to mental health diagnoses, 22.5% had an 
anxiety disorder, 70% a depressive disorder, and 7.5% 
had other disorders.
The mean score of the WHO-5 was 8.95 (SD=5.49). 
The lowest mean score obtained was 1.58 (SD=1.33) 
for item 4, and the highest mean score was 2.03 
(SD=1.20) for item 1 (Table 1).
In the present study, the mean scores of the other 
tools were calculated, and resulted as follows: PHQ-9, 
12.83 (SD=6.25); PHQ-15, 10.46 (SD=5.70); and BDI-
13, 9.65 (SD=5.92).
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Reliability coefficients of the WHO-5 
Cronbach’s α for the WHO-5 was 0.91, indicating 
high internal consistency. For the other questionnaires, 
Cronbach’s α values were as follows: PHQ-9, 0.88; 
PHQ-15, 0.85; and BDI-13, 0.80.
Inter-item and item-total correlations in the 
WHO-5
The correlations between items and the total score 
of the WHO-5 were high, ranging from 0.79 to 0.90. The 
correlations between items ranged from 0.54 for items 
3 and 5, to 0.75 for items 4 and 5, denoting moderate 
correlation (Table 2). 
Correlations between WHO-5 and other 
questionnaires
Table 3 shows the correlations between the WHO-5 
and other measures, demonstrating moderate validity 
and association between the instruments (Table 3). 
Factor analysis of the WHO-5
The Kaiser-Meyer-Olkin measure of sampling 
adequacy (KMO) was 0.874, indicating sample 
adequacy; Bartlett’s test of sphericity was 377.330 
(df=10, p<0.001), suggesting that factor analysis was 
justified in the sample. The results of the exploratory 
factor analysis on the WHO-5 found only one factor. 
Table 1 - Scores obtained for each WHO-5 item and total score
WHO-5 Minimum Maximum Mean SD
1.  Being cheerful and good spirits 0.00 5.00 2.03 1.20
2.  Being calm and relaxed 0.00 5.00 2.02 1.29
3.  Being active and vigorous 0.00 5.00 1.66 1.22
4.  Waking up fresh and rested 0.00 5.00 1.58 1.33
5.  Being interested in things 0.00 5.00 1.64 1.33
Total score 0.00 25.00 8.95 5.49
SD = standard deviation; WHO-5 = World Health Organization-5 Well-Being Index.
Table 2 - Pearson’s inter-item and item-total correlations (r)
Items 1 2 3 4 5 Total
1 1
2 0.736* 1
3 0.570* 0.617* 1
4 0.679* 0.742* 0.679* 1
5 0.650* 0.715* 0.547* 0.754* 1
Total 0.844* 0.890* 0.792* 0.902* 0.860* 1
* Significant at 0.01 level.
Table 3 - Pearson’s correlations (r) between the questionnaires
Questionnaires r with WHO-5
The PHQ-9 -0.358*
The PHQ-15 -0.328†
The BDI-13 -0.475†
BDI-13 = Beck Depression Inventory-13; PHQ-9 = Patient Health Questionnaire-9; 
PHQ-15 = Patient Health Questionnaire-15; WHO-5 = World Health Organization-5 
Well-Being Index.
* Significant at the 0.05 level.
† Significant at the 0.01 level.
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Factor 1 (5 items) explained 73.67% of the variance 
and was labeled psychological well-being (Table 4 and 
Figure 1). 
Discussion
The aim of the study was to investigate psychometric 
parameters for depression of the WHO-5 in an Iranian 
clinical sample. 
The mean score of the WHO-5 was 8.95 (SD=5.49), 
denoting poor psychological well-being in the sample. 
A study by Khosravi et al.25 reported a mean WHO-5 
score of 13.4 (SD=6.5) in an Iranian sample. In another 
study, the Thai version of the WHO-5 showed a mean 
score of 14.32 (SD=5.26) in primary care patients.24 
Cronbach’s α for the WHO-5 was 0.91, indicating 
good reliability. Other studies have shown good 
Cronbach’s α values for the WHO-5.1,16,20,21,24-26,40-45
Inter-item correlations were significant for items 3 
and 5, and also for items 4 and 5. The associations 
between the items and the WHO-5 total score were 
significant for items 3, 4, and the total score. 
In our study, the WHO-5 negatively correlated 
with the other measures assessed, denoting good 
validity. Findings of Khosravi et al.25 and Mortazavi 
et al.26 showed that the WHO-5 negatively correlated 
with the 28-item General Health Questionnaire (GHQ-
28; r=-0.66 and r=-0.64, respectively). The study 
by Blom et al.45 found that the WHO-5 negatively 
correlated with the Beck Depression Inventory (BDI-
6; r=-0.49). Guðmundsdóttir et al.40 reported that the 
Figure 1 - Scree plot for the World Health Organization-5 Well-Being Index (WHO-5).
Table 4 - Factor loadings of the WHO-5 in Iranian psychiatric outpatients 
WHO-5 Items Component
Over the last two weeks:
1.  I have felt cheerful and in good spirits. 0.84
2.  I have felt calm and relaxed. 0.89
3.  I have felt active and vigorous. 0.78
4.  I woke up feeling fresh and rested. 0.90
5.  My daily life has been filled with things that interest me. 0.85
Eigenvalue 3.68
% of Variance 73.67
WHO-5 = World Health Organization-5 Well-Being Index.
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WHO-5 negatively correlated with other inventories of 
depression and anxiety. Wu21 and Saipanish et al.24 found 
that the WHO-5 negatively correlated with the Hospital 
Anxiety and Depression Scale (HADS-Depression; -0.54 
and -0.57, respectively). Also, Wu21 indicated that the 
WHO-5 positively correlated with the World Health 
Organization Quality of Life (WHOQOL) and negatively 
associated with the PHQ-9 in patients with metabolic 
syndrome.
We identified one factor, labeled psychological well-
being, which accounted for 73.67% of the variance. Our 
finding is similar to previous studies that also obtained a 
single factor.2,21,24,25,38 It seems that the 1-factor solution 
represents the best fit for the WHO-5.
Conclusions
The validation process of the Farsi version of the 
WHO-5 showed psychometric parameters consistent 
with those reported in previous studies, suggesting that 
it measures concepts that are similar to those measured 
by the original version. The WHO-5 has a single 
dimensional structure and acceptable psychometric 
parameters.
The results of this study suggest that the WHO-5 can 
be used in a clinical context in Iran. The use of distinct 
cut-off points for different purposes and populations, 
Rasch’s item response theory (IRT) approaches, and 
receiver operating characteristic curve (ROC) for 
depression or more severe mental disorders, are all 
suggested. 
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